Insider transactions

EDGAR

REVANCE THERAPEUTICS, INC.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-22.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

This issuer has insider filings in the store, but no transaction in this window or code group.

Latest reported holdings

What each reporting owner last said they hold, as of the date shown. A transaction not yet filed is not in it.

Latest reported holdings
Reporting ownerSecurityShares owned afterDirect or indirectSource
Beraud Jill DirectorCommon Stock 0D As of 2025-02-06 Open filing 4
Coric Vlad DirectorCommon Stock 0D As of 2025-02-06 Open filing 4
Foley Mark J Director · Officer: CEOCommon Stock 110,913I See footnoteAs of 2025-02-05 Open filing 4
Foley Mark J Director · Officer: President CEOCommon Stock 0D As of 2025-02-06 Open filing 4
Foley Mark J Director · Officer: President CEOCommon Stock 0I See footnoteAs of 2025-02-04 Open filing 4
Gangolli Julian S DirectorCommon Stock 0D As of 2025-02-06 Open filing 4
Hollander David Officer: CMO Global Therapeutics LeadCommon Stock 0D As of 2025-02-06 Open filing 4
Jordan Erica Officer: Chief Commercial OfficerCommon Stock 0D As of 2025-02-06 Open filing 4
Kolaja Carey OConnor DirectorCommon Stock 0D As of 2025-02-06 Open filing 4
Moxie Dwight Officer: CLO GCCommon Stock 0D As of 2025-02-06 Open filing 4
Nolet Chris DirectorCommon Stock 0D As of 2025-02-06 Open filing 4
Russell Angus C. DirectorCommon Stock 0D As of 2025-02-06 Open filing 4
Schilke Tobin Officer: CFOCommon Stock 0D As of 2025-02-06 Open filing 4
Ware Olivia C DirectorCommon Stock 0D As of 2025-02-06 Open filing 4

Joint filers each report the same shares, so rows are not added together.

Institutional holders (Form 13F)

No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.

Institutional ownership reported on Form 13F

No percent is shown: the cover-page share count is not available for this company.

  • The lower figure counts positions a manager reports as its own with sole discretion. The upper figure counts every plain-share position and can count a share twice.
  • Neither includes holders that do not file Form 13F, or managers below the filing threshold.
Quarter-by-quarter 13F holders
QuarterManagers holdingShares, at leastShares, at mostFilings read
2026-09-30 0008,935
2026-06-30 0009,178
2026-03-31 0009,173
2025-12-31 0009,222
2025-09-30 10173,3558,469
2025-06-30 103,7058,516
2025-03-31 2086,1008,518
2024-12-31 17734,849,17284,738,0458,580

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read from their tags. Earlier schedules are free text: they are read only when every cover page states a share count and a percent, and the rest are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Beryl Capital Management LLC Common Stock, par value $0.001 per share1.61,642,448— Filed 2024-09-16SC 13GRead from the cover page textOpen filing 0000935836-24-000588 Dispute this row
Beryl Capital Management LP Common Stock, par value $0.001 per share1.61,642,448— Filed 2024-09-16SC 13GRead from the cover page textOpen filing 0000935836-24-000588 Dispute this row
Beryl Capital Partners II LP Common Stock, par value $0.001 per share1.31,412,133— Filed 2024-09-16SC 13GRead from the cover page textOpen filing 0000935836-24-000588 Dispute this row
David A. Witkin Common Stock, par value $0.001 per share1.61,642,448— Filed 2024-09-16SC 13GRead from the cover page textOpen filing 0000935836-24-000588 Dispute this row
Capital World Investors Common Stock6.66,948,769— Filed 2024-09-09SC 13G/AAmendment 4Read from the cover page textOpen filing 0001562230-24-000029 Dispute this row
JPMORGAN CHASE & CO. Common Stock, par value $0.001 per share2.62,768,691— Filed 2024-04-09SC 13G/AAmendment 10Read from the cover page textOpen filing 0000019617-24-000305 Dispute this row
Polar Capital Holdings Plc Common Stock, $0.001 par value per share3.603,169,239— Filed 2024-02-13SC 13G/AAmendment 1Read from the cover page textOpen filing 0001172661-24-000760 Dispute this row
Polar Capital LLP Common Stock, $0.001 par value per share3.603,169,239— Filed 2024-02-13SC 13G/AAmendment 1Read from the cover page textOpen filing 0001172661-24-000760 Dispute this row
The Vanguard Group - 23-1945930 Name of issuer: Revance Therapeutics Inc5.775,069,625— Filed 2024-02-13SC 13G/AAmendment 2Read from the cover page textOpen filing 0001104659-24-021835 Dispute this row
Capital World Investors Common Stock13.611,939,076— Filed 2024-02-09SC 13G/AAmendment 3Read from the cover page textOpen filing 0001422848-24-000290 Dispute this row
GIC Private Limited Common Stock, par value $0.001 per share6.635,825,881— Filed 2024-02-09SC 13G/AAmendment 4Read from the cover page textOpen filing 0001140361-24-006576 Dispute this row
JPMORGAN CHASE & CO. Common Stock, par value $0.001 per share5.44,754,771— Filed 2024-01-25SC 13G/AAmendment 09Read from the cover page textOpen filing 0000019617-24-000156 Dispute this row
BlackRock, Inc. Common Stock8.57,453,371— Filed 2024-01-25SC 13G/AAmendment 8Read from the cover page textOpen filing 0001086364-24-003237 Dispute this row
JPMORGAN CHASE & CO. Common Stock, par value $0.001 per share5.44,754,771— Filed 2024-01-25SC 13G/AAmendment 09Read from the cover page textOpen filing 0000019617-24-000145 Dispute this row
Teoxane SA Common Stock, par value $0.001 per share7.46,550,800— Filed 2023-10-24SC 13D/AAmendment 1Read from the cover page textOpen filing 0001140361-23-049319 Dispute this row
Teoxane SA Common Stock, par value $0.001 per share5.04,445,800— Filed 2023-09-01SC 13DRead from the cover page textOpen filing 0001140361-23-042206 Dispute this row
Antara Capital LP Common Stock, $.001 par value6.45,239,600— Filed 2023-02-14SC 13GRead from the cover page textOpen filing 0001193125-23-037217 Dispute this row
Antara Capital GP LLC Common Stock, $.001 par value6.45,239,600— Filed 2023-02-14SC 13GRead from the cover page textOpen filing 0001193125-23-037217 Dispute this row
Himanshu Gulati Common Stock, $.001 par value6.45,239,600— Filed 2023-02-14SC 13GRead from the cover page textOpen filing 0001193125-23-037217 Dispute this row
Polar Capital Holdings Plc Common Stock, $0.001 par value per share5.94,848,633— Filed 2023-02-14SC 13GRead from the cover page textOpen filing 0001172661-23-001298 Dispute this row
Polar Capital LLP Common Stock, $0.001 par value per share5.94,848,633— Filed 2023-02-14SC 13GRead from the cover page textOpen filing 0001172661-23-001298 Dispute this row
Capital World Investors Common Stock11.59,480,156— Filed 2023-02-13SC 13G/AAmendment 2Read from the cover page textOpen filing 0001422849-23-000128 Dispute this row
The Vanguard Group - 23-1945930 Name of issuer: Revance Therapeutics Inc.5.474,496,316— Filed 2023-02-09SC 13G/AAmendment 1Read from the cover page textOpen filing 0001104659-23-016848 Dispute this row
GIC Private Limited Common Stock, par value $0.001 per share6.685,492,965— Filed 2023-02-09SC 13G/AAmendment 3Read from the cover page textOpen filing 0001140361-23-005449 Dispute this row
BlackRock, Inc. Common Stock8.67,072,681— Filed 2023-02-03SC 13G/AAmendment 7Read from the cover page textOpen filing 0001306550-23-007655 Dispute this row
JPMORGAN CHASE & CO. Common Stock, par value $0.001 per share6.04,982,949— Filed 2023-01-27SC 13G/AAmendment 08Read from the cover page textOpen filing 0000019617-23-000167 Dispute this row
Capital World Investors Common Stock10.38,463,909— Filed 2022-12-09SC 13G/AAmendment 1Read from the cover page textOpen filing 0001422849-22-000177 Dispute this row
Not recorded Common Stock6.094,369,366— Filed 2022-02-14SC 13G/AAmendment 1Read from the cover page textOpen filing 0001306923-22-000009 Dispute this row
Not recorded Common Stock6.094,369,366— Filed 2022-02-14SC 13G/AAmendment 1Read from the cover page textOpen filing 0001306923-22-000009 Dispute this row
Not recorded Common Stock6.094,369,366— Filed 2022-02-14SC 13G/AAmendment 1Read from the cover page textOpen filing 0001306923-22-000009 Dispute this row
Not recorded Common Stock6.094,369,366— Filed 2022-02-14SC 13G/AAmendment 1Read from the cover page textOpen filing 0001306923-22-000009 Dispute this row
Capital World Investors Common Stock5.23,712,000— Filed 2022-02-11SC 13GRead from the cover page textOpen filing 0001422849-22-000132 Dispute this row
The Vanguard Group - 23-1945930 Name of issuer: Revance Therapeutics Inc.5.023,602,297— Filed 2022-02-10SC 13GRead from the cover page textOpen filing 0001104659-22-018458 Dispute this row
GIC Private Limited Common Stock, par value $0.001 per share5.824,176,080— Filed 2022-02-08SC 13G/AAmendment 2Read from the cover page textOpen filing 0001193125-22-031120 Dispute this row
Wellington Management Group LLP Common Stock1.541,104,531— Filed 2022-02-04SC 13G/AAmendment 7Read from the cover page textOpen filing 0001678858-22-000336 Dispute this row
Wellington Group Holdings LLP Common Stock1.541,104,531— Filed 2022-02-04SC 13G/AAmendment 7Read from the cover page textOpen filing 0001678858-22-000336 Dispute this row
Wellington Investment Advisors Holdings LLP Common Stock1.541,104,531— Filed 2022-02-04SC 13G/AAmendment 7Read from the cover page textOpen filing 0001678858-22-000336 Dispute this row
BlackRock, Inc. Common Stock7.45,334,099— Filed 2022-02-03SC 13G/AAmendment 6Read from the cover page textOpen filing 0000834237-22-006351 Dispute this row
JPMORGAN CHASE & CO. Common Stock, par value $0.001 per share9.46,794,223— Filed 2022-01-18SC 13G/AAmendment 07Read from the cover page textOpen filing 0000019617-22-000113 Dispute this row
ArrowMark Colorado Holdings, LLC Common Stock, par value $0.001 per share4.52,964,135— Filed 2021-02-16SC 13G/AAmendment 3Read from the cover page textOpen filing 0001172661-21-000642 Dispute this row
GIC Private Limited Common Stock, par value $0.001 per share5.763,830,951— Filed 2021-02-12SC 13G/AAmendment 1Read from the cover page textOpen filing 0001193125-21-041682 Dispute this row
BlackRock, Inc. Common Stock7.55,012,352— Filed 2021-02-05SC 13G/AAmendment 5Read from the cover page textOpen filing 0000834237-21-007453 Dispute this row
Wellington Management Group LLP Common Stock5.113,397,872— Filed 2021-02-04SC 13G/AAmendment 6Read from the cover page textOpen filing 0000902219-21-000299 Dispute this row
Wellington Group Holdings LLP Common Stock5.113,397,872— Filed 2021-02-04SC 13G/AAmendment 6Read from the cover page textOpen filing 0000902219-21-000299 Dispute this row
Wellington Investment Advisors Holdings LLP Common Stock5.113,397,872— Filed 2021-02-04SC 13G/AAmendment 6Read from the cover page textOpen filing 0000902219-21-000299 Dispute this row
Franklin Resources, Inc. Common Stock, par value $0.001 per share2.61,755,863— Filed 2021-02-02SC 13G/AAmendment 6Read from the cover page textOpen filing 0000038777-21-000038 Dispute this row
Charles B. Johnson Common Stock, par value $0.001 per share2.61,755,863— Filed 2021-02-02SC 13G/AAmendment 6Read from the cover page textOpen filing 0000038777-21-000038 Dispute this row
Rupert H. Johnson, Jr. Common Stock, par value $0.001 per share2.61,755,863— Filed 2021-02-02SC 13G/AAmendment 6Read from the cover page textOpen filing 0000038777-21-000038 Dispute this row
JPMORGAN CHASE & CO. Common Stock, par value $0.001 per share6.14,067,042— Filed 2021-01-29SC 13G/AAmendment 06Read from the cover page textOpen filing 0000019617-21-000180 Dispute this row
Wellington Management Group LLP Common Stock5.683,743,700— Filed 2020-08-10SC 13G/AAmendment 5Read from the cover page textOpen filing 0000902219-20-000421 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

3,104,499 filings read, dated 1980-01-02 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015258,595
2016246,472
2017244,814
2018245,575
2019238,619
2020249,093
2021274,850
2022257,922
2023253,676
2024261,106
2025235,525
2026263,830

Filings made before the SEC required XML are listed, not extracted.

Back to REVANCE THERAPEUTICS, INC.